vious report also suggests that hyperhomocysteinaemia is important in the development of diabetic nephropathy [7] . The same group reported an association of the C677T variant with diabetic nephropathy [8] . These observations suggest that the C677T mutation could be associated with diabetic nephropathy, in which genetic predisposition is thought to be important. To investigate its possible association with diabetic nephropathy, we analysed 274 unrelated Japanese patients with Type II (non-insulin-dependent) diabetes mellitus with (77 men/ 66 women, mean (SD): 59.4 (12.2) years old, range: 29±87 years) or without (86 men/45 women, 57.4 (10.6), 24±85 years) nephropathy for the presence of the C677T mutation of the MTHFR gene. Age (p = 0.14, t test), age at onset of diabetes Genotypes Alleles phropathy (chi-squared = 0.037, p = 0.85). The T allele frequency was not different between the two groups (Fisher's exact test, p = 0.34) ( Table 1 ). The genotype frequencies were not different by comparing patients with macroalbuminuria (Urine > 300 micrograms/day) or microalbuminuria (> 30 micrograms/day) with those without nephropathy (< 30 micrograms/day) (data not shown). Although the C ® T mutation has been reported to be associated with diabetic retinopathy and nephropathy in the previous reports from the same group [6, 8] , its association was absent with diabetic nephropathy in the group analysed. This difference is not likely to be attributable to ethnic differences in the genetic predisposition [9] as both of the groups analysed are Japanese [8] . As the role of homocysteine metabolism in the pathogenesis of diabetic microangiopathies is largely not known, it is currently not possible to explain its association with diabetic nephropathy. In conclusion, although previous observations suggest a role for the C677T mutation of the MTHFR gene in the development of diabetic nephropathy, it seems to be premature to conclude that this mutation is associated with diabetic nephropathy in Japanese people.
Yours sincerely, M. Odawara, K. Yamashita
Is Trp64Arg polymorphism of b 3 -adrenergic receptor a clinically useful marker for the predisposition to diabetic nephropathy in Type II diabetic patients?
Dear Sir, The Trp64Arg polymorphism in the b 3 -adrenergic receptor (b 3 -AR) gene has been found to be associated with early development of Type II (non-insulin-dependent) diabetes mellitus, low resting metabolic rate, clinical features of the insulin resistance syndrome, and abdominal obesity. A relation between b 3 -AR Trp64Arg polymorphism and increased blood pressure, higher serum cholesterol, increased serum triglycerides and lower HDL-cholesterol has also been shown. Specific b 3 adrenoreceptor agonists were shown to increase cutaneous, as well as pancreatic islet blood flow. Thus, the role of the b 3 -AR Trp64Arg polymorphism in aggravating microvascular complications in diabetes was postulated. Recently, Sakane et al. found a positive association between the b 3 -AR Trp64Arg polymorphism and proliferative retinopathy [1] , as well as overt nephropathy [2] in Japanese Type II diabetic patients. We examined whether b 3 -AR Trp64Arg contributes to the predisposition to microalbuminuria or overt proteinuria or both in a large group of Caucasian patients with Type II diabetes. During a period of 6 months, each day, on average the first 10 Type II diabetic patients attending the Outpatient Clinic for Diabetic Patients in Zabrze, residents of Zabrze, were screened for microalbuminuria (as repeated measurements of albumin : creatinine ratio [ACR] in random urine samples). Determination of renal status was based on the criteria proposed previously [3] and careful review of medical records. In total, 941 patients with established nephropathy and retinopathy status were collected [4] . From that group, 126 patients with overt proteinuria or chronic renal failure (CRF), 330 microalbuminuric patients, and a control group of 249 normoalbuminuric patients with at least 10 years of known diabetes duration were selected for the case-control comparisons and were genotyped at the b 3 -AR Trp64Arg locus. The overall frequency of the Arg allele was 9.3 %, which is comparable to that observed in other Caucasian samples but lower than that among the Japanese and Pima Indians. We observed no significant differences in genotype distributions, as well as allele frequencies between patients with normoalbuminuria, microalbuminuria or macroalbuminuria (Table 1) .
Recently, Sakane et al. found an increased frequency of the homozygous Arg/Arg genotype among 62 overt proteinuric Japanese Type II diabetic patients (5 Arg/Arg carriers, 57 noncarriers), compared with 176 normoalbuminuric control subjects (4/172) [2] . The authors concluded, that the presence of a homozygous genotype was a clinically useful marker for the increased risk of the development of diabetic nephropathy. Caution should be used, however, in the interpretation of these findings.
